150 related articles for article (PubMed ID: 31289357)
1. Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation.
Rehm SRT; Smirnova NF; Morrone C; Götzfried J; Feuchtinger A; Pedersen J; Korkmaz B; Yildirim AÖ; Jenne DE
Sci Rep; 2019 Jul; 9(1):9925. PubMed ID: 31289357
[TBL] [Abstract][Full Text] [Related]
2. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
[TBL] [Abstract][Full Text] [Related]
3. Preservation with α
Götzfried J; Smirnova NF; Morrone C; Korkmaz B; Yildirim AÖ; Eickelberg O; Jenne DE
J Heart Lung Transplant; 2018 Aug; 37(8):1021-1028. PubMed ID: 29776812
[TBL] [Abstract][Full Text] [Related]
4. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin C inhibition as a potential treatment strategy in cancer.
Korkmaz B; Lamort AS; Domain R; Beauvillain C; Gieldon A; Yildirim AÖ; Stathopoulos GT; Rhimi M; Jenne DE; Kettritz R
Biochem Pharmacol; 2021 Dec; 194():114803. PubMed ID: 34678221
[TBL] [Abstract][Full Text] [Related]
6. Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation.
Paulus P; Holfeld J; Urbschat A; Mutlak H; Ockelmann PA; Tacke S; Zacharowski K; Reissig C; Stay D; Scheller B
PLoS One; 2013; 8(8):e73298. PubMed ID: 24009745
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.
Liu B; Korkmaz B; Kraft P; Mayer T; Sayour AA; Grundl MA; Domain R; Karck M; Szabó G; Korkmaz-Icöz S
J Transl Med; 2023 Nov; 21(1):799. PubMed ID: 37946197
[TBL] [Abstract][Full Text] [Related]
8. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting.
Kim H; Zamel R; Bai XH; Lu C; Keshavjee S; Keshavjee S; Liu M
Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L595-L608. PubMed ID: 30024306
[TBL] [Abstract][Full Text] [Related]
10. Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Korkmaz B; Lesner A; Marchand-Adam S; Moss C; Jenne DE
J Med Chem; 2020 Nov; 63(22):13258-13265. PubMed ID: 32692176
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.
Basso J; Chen KJ; Zhou Y; Mark L; LaSala D; Dorfman A; Atalla M; Chun D; Viramontes V; Chang C; Leifer F; McDonald PP; Cipolla DC
Front Pharmacol; 2023; 14():1208780. PubMed ID: 37538173
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C.
Korkmaz B; Lesner A; Wysocka M; Gieldon A; Håkansson M; Gauthier F; Logan DT; Jenne DE; Lauritzen C; Pedersen J
Biochem Pharmacol; 2019 Jun; 164():349-367. PubMed ID: 30978322
[TBL] [Abstract][Full Text] [Related]
13. Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases.
Hamon Y; Legowska M; Hervé V; Dallet-Choisy S; Marchand-Adam S; Vanderlynden L; Demonte M; Williams R; Scott CJ; Si-Tahar M; Heuzé-Vourc'h N; Lalmanach G; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2016 Apr; 291(16):8486-99. PubMed ID: 26884336
[TBL] [Abstract][Full Text] [Related]
14. A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion.
Harada M; Oto T; Otani S; Miyoshi K; Okada M; Iga N; Nishikawa H; Sugimoto S; Yamane M; Miyoshi S
Gen Thorac Cardiovasc Surg; 2015 Dec; 63(12):645-51. PubMed ID: 26346003
[TBL] [Abstract][Full Text] [Related]
15. Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review.
Forgie KA; Fialka N; Freed DH; Nagendran J
Cells; 2021 Jun; 10(6):. PubMed ID: 34200413
[TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice.
Dai R; Cowan C; Heid B; Khan D; Liang Z; Pham CT; Ahmed SA
PLoS One; 2017; 12(2):e0172105. PubMed ID: 28192517
[TBL] [Abstract][Full Text] [Related]
18. Discovery and
Chen X; Yan Y; Zhang Z; Zhang F; Liu M; Du L; Zhang H; Shen X; Zhao D; Shi JB; Liu X
J Med Chem; 2021 Aug; 64(16):11857-11885. PubMed ID: 34374541
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Korkmaz B; Caughey GH; Chapple I; Gauthier F; Hirschfeld J; Jenne DE; Kettritz R; Lalmanach G; Lamort AS; Lauritzen C; Łȩgowska M; Lesner A; Marchand-Adam S; McKaig SJ; Moss C; Pedersen J; Roberts H; Schreiber A; Seren S; Thakker NS
Pharmacol Ther; 2018 Oct; 190():202-236. PubMed ID: 29842917
[TBL] [Abstract][Full Text] [Related]
20. Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.
Hou W; Sun H; Ma Y; Liu C; Zhang Z
J Med Chem; 2019 Jun; 62(12):5901-5919. PubMed ID: 31145622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
